DNAprint Genomics (DNAG)

[mingwan0]

Biofrontera's clinical development stage projects

We saw from the 8K yesterday that projects in this category include two items:

- Histidine decarboxylase inhibitor (Phase II)
- Skin cancer drug (Phase II, inlicensing deal currently closed)

The first of these is BF-Derm 1 (the Urticaria drug). The second one though does not appear on the Biofrontera website or in any of the press releases (unless I have missed it). This must therefore be a recent development.